NCT01758627View on ClinicalTrials.gov

The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 8, 2015

Study Completion Date

October 8, 2015

Conditions
Refractory Heart FailureChronic Kidney Disease
Interventions
DRUG

Peritoneal dialysis (PD)

PD exchanges will be customized depending on patient fluid status. At least one daily exchange of icodextrin PD solution will be provided to PD group.

Trial Locations (1)

120-752

Division of Nephrology, Department of Internal Medicine Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01758627 - The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease | Biotech Hunter | Biotech Hunter